Anika Therapeutics Inc.

NASDAQ: ANIK · Real-Time Price · USD
8.79
0.15 (1.74%)
At close: Aug 15, 2025, 9:57 AM

Anika Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.3 -4.02 -29.01 124.82
PEG Ratio
0.13 -0.01 0.06 -1.07
PS Ratio
2.02 1.99 2.76 3.49
PB Ratio
1.57 1.56 1.51 1.80
P/FCF Ratio
-103.95 -46.03 -140.07 158.57
P/OCF Ratio
44.85 -185.74 97.76 61.45
OCF/S Ratio
0.05 -0.01 0.03 0.06
Debt / Equity Ratio
0.17 0.14 0.11 0.07
Quick Ratio
3.85 3.76 4.65 4.45
Current Ratio
4.88 5.26 6.07 5.66
Asset Turnover
0.59 0.62 0.45 0.43
Interest Coverage
n/a n/a -29.66 n/a
Return on Equity
-0.37 -0.39 -0.05 0.01
Return on Assets
-0.28 -0.31 -0.04 0.01
Return on Invested Capital
-0.09 -0.35 -0.05 -0.1
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.63 0.62 0.60 0.56
Net Profit Margin
-0.47 -0.5 -0.1 0.03
Pretax Profit Margin
-0.02 -0.51 -0.12 0.02
Operating Profit Margin
-0.04 -0.53 -0.12 -0.13
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
0.03 -0.07 -0.03 0.02